(Q47982219)

7 February 2018

title

Are the ICD-10 or DSM-5 diagnostic systems able to define those who will benefit from treatment for depression? (English)

1 reference

7 February 2018

author name string

Stuart Montgomery

series ordinal

1

1 reference

7 February 2018

publication date

15 July 2016

1 reference

7 February 2018

published in

C N S Spectrums

1 reference

7 February 2018

volume

21

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

283-288

1 reference

7 February 2018

A New Depression Scale Designed to be Sensitive to Change

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

Efficacy of treatments for anxiety disorders: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

ICD-11 should not repeat the mistakes made by DSM-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

Switching antidepressant class does not improve response or remission in treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852916000389

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1092852916000389

1 reference

7 February 2018

PubMed ID

27418397

1 reference

7 February 2018